Protagonist Therapeutics adopts 2026 Equity Incentive Plan
Protagonist Therapeutics' board adopted and stockholders approved a new 2026 Equity Incentive Plan on June 17, 2026, succeeding the prior 2016 plan. The new plan expands share reserves and provides equity awards to employees, directors, and consultants to retain talent and align incentives with company performance.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
GET FREE KEY — 10,000 calls/day